Opus Genetics, Inc.(IRD)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
IRD | 333.6 M | - | -73.80% | 0.00% | -$1.27 | -4796.52% | - | 0.00% | $7.07 | $1.70 |
CCCC | 388.8 M | - | 2.80% | -289.44% | -$0.95 | -48.14% | 0.23x | 0.00% | $5.17 | $1.69 |
GALT | 345.9 M | - | - | 0.00% | -$0.41 | - | - | 0.00% | $7.13 | $2.03 |
ENTA | 339.9 M | - | -21.60% | -96.89% | -$2.42 | -70.12% | 1.80x | 0.00% | $17.15 | $10.20 |
ZNTL | 234.5 M | - | - | 0.00% | -$1.96 | -66.75% | 0.26x | 0.00% | $6.95 | $1.21 |
Peer Valuation & Performance Analysis
Peer group analysis for Opus Genetics, Inc. (IRD) compared to its primary competitors (including CCCC, GALT, ENTA) reveals distinct metrics. IRD trades at a valuation premium compared to its competitors, with a P/E ratio of -3.2x versus the peer average of -4.4x (representing a -29% premium). This indicates that the market expects superior growth or commands a quality premium for IRD. In terms of growth, IRD's revenue growth of -73.8% lags behind the peer average of -9.4%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 0.0% compared to the peer average of -96.6%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• IRD ranks #0 in P/E ratio, #3 in revenue growth, and #1 in profit margins
• Average ranking: #1 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $3.82 | $4.14 | $3.78 | $4.01 | 1,454,745 | +4.97% |
| 2026-10-19 | $3.87 | $3.94 | $3.69 | $3.82 | 1,527,200 | -0.52% |
| 2026-10-16 | $4.12 | $4.13 | $3.75 | $3.84 | 2,527,000 | -5.19% |
| 2026-10-15 | $4.15 | $4.28 | $3.98 | $4.05 | 2,952,900 | -1.22% |
| 2026-10-14 | $4.40 | $4.40 | $4.08 | $4.10 | 1,198,400 | -3.30% |
| 2026-10-13 | $4.76 | $4.77 | $4.23 | $4.24 | 1,291,500 | -8.62% |
| 2026-10-12 | $4.63 | $4.88 | $4.60 | $4.64 | 1,623,200 | -0.22% |
| 2026-10-09 | $4.46 | $4.74 | $4.45 | $4.65 | 1,255,400 | +4.26% |
| 2026-10-08 | $4.41 | $4.48 | $4.25 | $4.46 | 1,345,700 | +1.13% |
| 2026-10-07 | $4.35 | $4.66 | $4.25 | $4.41 | 1,839,800 | +0.68% |
| 2026-10-06 | $4.47 | $4.48 | $4.19 | $4.38 | 2,534,000 | +0.00% |
| 2026-10-05 | $4.57 | $4.64 | $4.34 | $4.38 | 2,534,900 | -4.37% |
| 2026-10-02 | $4.56 | $4.67 | $4.45 | $4.58 | 1,789,500 | +1.55% |
| 2026-10-01 | $4.89 | $4.91 | $4.51 | $4.51 | 1,873,800 | -6.82% |
| 2026-09-30 | $4.96 | $5.32 | $4.83 | $4.84 | 2,458,000 | -2.42% |
Explore More Analysis for IRD
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.